TY - Generic T1 - Efficacy and safety of 8-week glecaprevir/pibrentasvir in treatment-naive patients with chronic hepatitis c virus genotype 1, 2, 3, 4, 5, or 6 infection and compensated cirrhosis: EXPEDITION-8 complete results [abstract LP9] T2 - Presented at Liver Meeting, 2019; November 8-12 Y1 - 2019 A1 - Brown, RS A1 - Buti, M A1 - Rodrigues, L A1 - et, al JA - Presented at Liver Meeting, 2019; November 8-12 CY - Boston, Massachusetts ER -